Yuflyma Kit
NDC Package 72606-030-08
Package Information
Yuflyma (adalimumab-aaty) kits is none. This formulation utilizes a kit delivery system. Marketed by Celltrion Usa, Inc., this product is identified by NDC 72606-030 and is authorized under FDA application BLA761219.
Identification & Billing
- RxCUI: 2639651 - adalimumab-aaty 40 MG in 0.4 ML Auto-Injector
- RxCUI: 2639651 - 0.4 ML adalimumab-aaty 100 MG/ML Auto-Injector
- RxCUI: 2639651 - adalimumab-aaty 40 MG per 0.4 ML Auto-Injector
- RxCUI: 2639657 - Yuflyma 40 MG in 0.4 ML Auto-Injector
- RxCUI: 2639657 - 0.4 ML adalimumab-aaty 100 MG/ML Auto-Injector [Yuflyma]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 72606 - Celltrion Usa, Inc.
- 72606-030 - Yuflyma
- 72606-030-08 - 6 KIT in 1 CARTON / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 1 mL in 1 PACKET
- 72606-030 - Yuflyma
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (72606-030). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72606-030-08 identifies a specific commercial package of 6 kit in 1 carton / 1 kit in 1 kit * 1 syringe in 1 tray / .4 ml in 1 syringe * 1 ml in 1 packet of Yuflyma, a human prescription drug labeled by Celltrion Usa, Inc.. This kit is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Celltrion Usa, Inc. on May 23, 2023. The current certification is valid through December 31, 2026.
How is this Celltrion Usa, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72606003008. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
